Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi

被引:190
|
作者
Jahn, Andreas [1 ]
Floyd, Sian [1 ]
Crampin, Amelia C. [1 ]
Mwaungulu, Frank [2 ]
Mvula, Hazzie [2 ]
Munthali, Fipson [2 ]
McGrath, Nuala [1 ]
Mwafilaso, Johnbosco [2 ]
Mwinuka, Venance [2 ]
Mangongo, Bernard [2 ]
Fine, Paul E. M. [1 ]
Zaba, Basia [1 ]
Glynn, Judith R. [1 ]
机构
[1] Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1E 7HT, England
[2] Karonga Prevent Study, Karonga, Malawi
来源
LANCET | 2008年 / 371卷 / 9624期
基金
英国惠康基金;
关键词
D O I
10.1016/S0140-6736(08)60693-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Malawi, which has about 80000 deaths from AIDS every year, made free antiretroviral therapy available to more than 80000 patients between 2004 and 2006. We aimed to investigate mortality in a population before and after the introduction of free antiretroviral therapy, and therefore to assess the effects of such programmes on survival at the population level. Methods We used a demographic surveillance system to measure mortality in a population of 32 000 in northern Malawi, from August, 2002, when free antiretroviral therapy was not available in the study district, until February, 2006, 8 months after a clinic opened. Causes of death were established through verbal autopsies (retrospective interviews). Patients who registered for antiretroviral therapy at the clinic were identified and linked to the population under surveillance. Trends in mortality were analysed by age, sex, cause of death, and zone of residence. Findings Before antiretroviral therapy became available in June, 2005, mortality in adults (aged 15-59 years) was 9.8 deaths for 1000 person-years of observation (95% CI 8.9-10.9). The probability of dying between the ages of 15 and 60 years was 43% (39-49) for men and 43% (38-47) for women; 229 of 352 deaths (65 . 1%) were attributed to AIDS. 8 months after the clinic that provided antiretroviral therapy opened, 107 adults from the study population had accessed treatment, out of an estimated 334 in need of treatment. Overall mortality in adults had decreased by 10% from 10 . 2 to 8.7 deaths for 1000 person-years of observation (adjusted rate ratio 0 . 90, 95% Cl 0 . 70-1.14). Mortality was reduced by 35% (adjusted rate ratio 0 . 65, 0.46.0 . 92) in adults near the main road, where mortality before antiretroviral therapy was highest (from 13.2 to 8.5 deaths per 1000 person-years of observation before and after antiretroviral therapy). Mortality in adults aged 60 years or older did not change. Interpretation Our findings of a reduction in mortality in adults aged between 15 and 59 years, with no change in those older than 60 years, suggests that deaths from AIDS were averted by the rapid scale-up of free antiretroviral therapy in rural Malawi, which led to a decline in adult mortality that was detectable at the population level. Funding Wellcome Trust and British Leprosy Relief Association.
引用
下载
收藏
页码:1603 / 1611
页数:9
相关论文
共 36 条
  • [11] Population-level associations between antiretroviral therapy scale-up and all-cause mortality in South Africa
    Larson, Elysia
    Bendavid, Eran
    Tuoane-Nkhasi, Maletela
    Mbengashe, Thobile
    Goldman, Thurma
    Wilson, Melinda
    Klausner, Jeffrey D.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2014, 25 (09) : 636 - 642
  • [12] HIV related and non-HIV related mortality before and after the introduction of highly active antiretroviral therapy (HAART) in Norway compared to the general population
    Ormaasen, Vidar
    Sandvik, Leiv
    Dudman, Susanne G.
    Bruun, Johan N.
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2007, 39 (01) : 51 - 57
  • [13] A Population-Level Evaluation of the Effect of Antiretroviral Therapy on Cancer Incidence in Kyadondo County, Uganda, 1999-2008
    Mutyaba, Innocent
    Phipps, Warren
    Krantz, Elizabeth M.
    Goldman, Jason D.
    Nambooze, Sarah
    Orem, Jackson
    Wabinga, Henry R.
    Casper, Corey
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 69 (04) : 481 - 486
  • [14] Population-level effect of HSV-2 therapy on the incidence of HIV in sub-Saharan Africa
    White, R. G.
    Freeman, E. E.
    Orroth, K. K.
    Bakker, R.
    Weiss, H. A.
    O'Farrell, N.
    Buve, A.
    Hayes, R. J.
    Glynn, J. R.
    SEXUALLY TRANSMITTED INFECTIONS, 2008, 84 : II12 - II18
  • [15] Immunologic Risk Factors for Early Mortality After Starting Antiretroviral Therapy in HIV-Infected Zambian Children
    Rainwater-Lovett, Kaitlin
    Nkamba, Hope C.
    Mubiana-Mbewe, Mwangelwa
    Moore, Carolyn Bolton
    Moss, William J.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (03) : 479 - 487
  • [16] No evidence for hypoadrenalism as a cause of early mortality in a high HIV/TB prevalence population starting anti-tuberculosis treatment in Malawi
    Beadsworth, M. B. J.
    van Oosterhout, J. J.
    Diver, M.
    Shenkin, A.
    Mwandumba, H. C.
    Khoo, S.
    O'Dempsey, T.
    Squire, S. B.
    Zijlstra, E. E.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S454 - S454
  • [17] Impact of early antiretroviral therapy eligibility on HIV acquisition: household-level evidence from rural South Africa
    Oldenburg, Catherine E.
    Bor, Jacob
    Harling, Guy
    Tanser, Frank
    Mutevedzi, Tinofa
    Shahmanesh, Maryam
    Seage, George R.
    De Gruttola, Victor
    Mimiaga, Matthew J.
    Mayer, Kenneth H.
    Pillay, Deenan
    Baernighausen, Till
    AIDS, 2018, 32 (05) : 635 - 643
  • [18] No evidence for hypoadrenalism as a cause of early mortality in a high HIV/TB prevalence population starting anti-tuberculosis treatment (ATT) in Malawi
    Beadsworth, M.
    VanOosterhout, J.
    Diver, M.
    Farragher, B.
    Shenkin, A.
    Mwandumba, H.
    Khoo, S.
    O'Dempsey, T.
    Squire, B.
    Zijlstra, E.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2007, 12 : 243 - 243
  • [19] Black-white mortality from HIV in the United States before and after introduction of highly active antiretroviral therapy in 1996
    Levine, Robert S.
    Briggs, Nathaniel C.
    Kilbourne, Barbara S.
    King, William D.
    Fry-Johnson, Yvonne
    Baltrus, Peter T.
    Husaini, Baqar A.
    Rust, George S.
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2007, 97 (10) : 1884 - 1892
  • [20] Limited effect of highly active antiretroviral therapy among HIV-positive injecting drug users on the population level
    Van Asten, LC
    Boufassa, F
    Schiffer, V
    Brettle, RP
    Robertson, JR
    Aguado, IH
    McMenamin, J
    Zangerle, R
    Fontanet, A
    Coutinho, RA
    Prins, M
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2003, 13 (04): : 347 - 349